Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
590.55
Change Change %
-1.80 -0.30%

Updated:13 Nov, 2018, 15:47 PM IST

BSE
590.05
Change Change %
-0.10 -0.02%

Updated:13 Nov, 2018, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Axis Capital
N/A
05-07-2016 Hold 577.60 600.00
N/A
Target Hit Long (1Y)
05-07-2017

Axis Capital upgrades Alembic Pharma to hold

Axis Capital has upgraded Alembic Pharma to 'hold' from 'sell' for target of Rs 600/share. It says company is fast-tracking R&D initiatives and capacity expansion remains the key focus. It adds that the US revenues have benefited from gAbilify in FY16 and company is building infrastructure by investing extensively. Oncology, injectables & dermatology will drive growth for the company going ahead.

Top